0001562180-18-004909.txt : 20181211 0001562180-18-004909.hdr.sgml : 20181211 20181211172533 ACCESSION NUMBER: 0001562180-18-004909 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181207 FILED AS OF DATE: 20181211 DATE AS OF CHANGE: 20181211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: IGUCHI KIMI CENTRAL INDEX KEY: 0001304815 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36544 FILM NUMBER: 181229550 MAIL ADDRESS: STREET 1: 100 FOXBOROUGH BOULEVARD STREET 2: SUITE 240 CITY: FOXBOROUGH STATE: MA ZIP: 02035 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sage Therapeutics, Inc. CENTRAL INDEX KEY: 0001597553 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-299-8380 MAIL ADDRESS: STREET 1: 215 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2018-12-07 false 0001597553 Sage Therapeutics, Inc. SAGE 0001304815 IGUCHI KIMI C/O SAGE THERAPEUTICS, INC. 215 FIRST STREET CAMBRIDGE MA 02142 false true false false CFO & Treasurer Stock Option (Right to Buy) 47.70 2018-12-07 4 A false 7425.00 0.00 A 2027-02-06 Common Stock 7425.00 7425.00 D On February 6, 2017, the reporting person was granted an option to purchase 22,500 shares of common stock. The option vests upon the achievement of certain milestones, one of which was met on December 7, 2018, resulting in the vesting of the option as to 7,425 shares. /s/ Anne Marie Cook, as Attorney-in-Fact for Kimi Iguchi 2018-12-11